MedPath

A pilot randomised control trial, in intensive care patients, comparing seven days versus two days treatment with empirical antibiotics to treat hospital acquired infection of unknown origin - Randomised Empirical Antibiotic Duration in Intensive Care Unit

Phase 1
Conditions
Healthcare associated infections This includes infections of the: • Skin and underneath the skin, including muscle - sometimes called ‘soft tissue’ • Urinary tract - including your kidneys or bladder • Lungs - which affect your breathing • Joints and bones - including your hips or knees . Blood - sometimes called ‘septacaemia’ . Meningitis
Registration Number
EUCTR2009-015800-25-GB
Lead Sponsor
The Liverpool Heart & Chest Hospital NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Patients in the intensive care unit with signs suggestive of new infection in the absence of positive microbiological cultures
AND
At least two of the four markers of systemic inflammatory response syndrome (SIRS):
•temperature of >380C or <360C
•tachycardia (>90 beats per minute)
•tachypnoea (= 20 breaths per minute)
•white blood count >12x109/L or <4x109/L

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Positive microbiological cultures before randomisation
•Patients <18 years of age
•Unable to obtain assent or consent
•Patients enrolled in another study such that randomisation in READ-ICU would result in deviation from either protocol
•Known allergy to treatment antibiotics

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath